Invesco Ltd. boosted its holdings in shares of Mativ Holdings, Inc. (NYSE:MATV - Free Report) by 62.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 943,771 shares of the company's stock after purchasing an additional 364,117 shares during the quarter. Invesco Ltd. owned approximately 1.74% of Mativ worth $10,287,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of MATV. Barclays PLC lifted its position in shares of Mativ by 227.5% during the 3rd quarter. Barclays PLC now owns 102,836 shares of the company's stock valued at $1,748,000 after buying an additional 71,436 shares in the last quarter. Geode Capital Management LLC increased its stake in shares of Mativ by 1.2% during the third quarter. Geode Capital Management LLC now owns 1,243,514 shares of the company's stock worth $21,132,000 after purchasing an additional 14,766 shares in the last quarter. Virtu Financial LLC acquired a new position in shares of Mativ during the 3rd quarter worth about $338,000. Franklin Resources Inc. lifted its stake in Mativ by 8.3% in the 3rd quarter. Franklin Resources Inc. now owns 34,362 shares of the company's stock valued at $574,000 after buying an additional 2,648 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its holdings in Mativ by 44.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 196,822 shares of the company's stock worth $3,344,000 after buying an additional 60,930 shares during the last quarter. 94.95% of the stock is owned by institutional investors and hedge funds.
Mativ Stock Performance
NYSE:MATV opened at $4.92 on Wednesday. Mativ Holdings, Inc. has a twelve month low of $4.34 and a twelve month high of $19.96. The company has a market cap of $267.96 million, a P/E ratio of -5.46, a P/E/G ratio of 1.08 and a beta of 0.68. The company has a current ratio of 2.40, a quick ratio of 1.29 and a debt-to-equity ratio of 1.28. The company's 50-day moving average price is $6.27 and its 200-day moving average price is $10.25.
Mativ (NYSE:MATV - Get Free Report) last issued its earnings results on Wednesday, February 19th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.22 by ($0.17). Mativ had a positive return on equity of 3.86% and a negative net margin of 2.46%. The company had revenue of $458.60 million for the quarter, compared to analyst estimates of $472.70 million. On average, sell-side analysts forecast that Mativ Holdings, Inc. will post 1.15 earnings per share for the current fiscal year.
Mativ Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, March 28th. Shareholders of record on Friday, March 14th were paid a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a dividend yield of 8.14%. The ex-dividend date of this dividend was Friday, March 14th. Mativ's dividend payout ratio (DPR) is presently -44.44%.
Wall Street Analysts Forecast Growth
Separately, Stifel Nicolaus raised Mativ from a "hold" rating to a "buy" rating and lowered their price target for the stock from $15.50 to $10.00 in a research note on Monday, March 24th.
Check Out Our Latest Research Report on MATV
Mativ Company Profile
(
Free Report)
Mativ Holdings, Inc, together with its subsidiaries, manufactures and sells specialty materials in the United States, Europe, the Asia Pacific, the Americas, and internationally. The company operates through two segments, Advanced Technical Materials and Fiber-Based Solutions. The Advanced Technical Materials manufactures and sells various engineered polymer, resin and fiber-based substrates, nets, films, adhesive tapes, and other nonwovens for the filtration, protective solutions, release liners, and healthcare end-markets.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Mativ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mativ wasn't on the list.
While Mativ currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.